Search

Search Constraints

You searched for: Author/Creator Freed, Jason A.

Search Results

9. Responses to the multitargeted MET/ALK/ROS1 inhibitor crizotinib and co-occurring mutations in lung adenocarcinomas with MET amplification or MET exon 14 skipping mutation. Issue 3 (December 2015)